一个生物信息学和实验研究,以实现新的治疗策略:痛风进展中的CXCL8
Chao Zhang1, Chunhong Liu2, Xiaoming Yang2
1Department of Nephrology, Tongling Hospital of Traditional Chinese Medicine, Tongling, Anhui, China.
Medicine
|March 6, 2026
概括
痛风的进展包括炎症和免疫激活,即使没有高尿酸. 这项研究确定了C-X-C动机化学因子配体8 (CXCL8) 作为关键调解物,表明其作为痛风生物标志物和治疗点的潜力.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 生物信息学是一种生物信息学.
背景情况:
- 痛风是一种慢性炎症性疾病,与高尿血和免疫激活有关.
- 痛风诊断因没有尿酸升高的情况下发生的病例而复杂,需要可靠的分子生物标志物.
- 驱动痛风进展的精确分子机制尚未完全理解.
研究的目的:
- 为了研究导致痛风进展的分子机制.
- 确定潜在的分子生物标志物和痛风的治疗点.
- 探索C-X-C动机化学因配体8 (CXCL8) 在痛风病变发生过程中的作用.
主要方法:
- 从痛风患者和健康对照对转录基因数据集的综合生物信息学分析.
- 功能丰富,蛋白质与蛋白质相互作用网络,免疫细胞透和竞争性内源RNA网络分析.
- 在体外实验中评估细胞中高尿血症诱导的炎症反应.
主要成果:
- 鉴定了1848个不同表达的基因,主要在免疫和炎症途径中.
- 突出了五个枢纽基因,其中C-X-C动机化学因配体8 (CXCL8) 被确定为免疫细胞激活的关键调解者.
- 实验验证显示尿酸诱导的炎升高,并通过NLRP3炎症酶途径增加CXCL8表达.
结论:
- 预先确定C-X-C动机化学基因配体8 (CXCL8) 是痛风进展中的关键炎症调解剂.
- CXCL8显示出作为痛风诊断分子生物标志物的潜力.
- CXCL8代表了治疗痛风及其相关炎症的潜在治疗标.
更多相关视频
08:52Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
3.6K
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
14.6K
相关概念视频
The JAK-STAT Signaling Pathway
13.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.5K
Genome-wide Association Studies-GWAS
16.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.2K
NF-κB-dependent Signaling Pathway
10.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.2K
